Our previous study found that the downregulation of RFX1 in CD4+ T cells from peripheral blood of patients with SLE promoted T cell autoreactive activation and increased Th17 cell differentiation, which is involved in the pathogenesis of SLE (20–22). The gene discussed is RFX1; the disease is systemic lupus erythematosus.